Linking differential radiation responses to glioma heterogeneity.
The phenotypic and genetic diversity that define tumor subpopulations within high-grade glioma can lead to therapeutic resistance and tumor recurrence. Given that cranial irradiation is a frontline treatment for malignant glioma, understanding how irradiation selectively effects different cellular subpopulations within these heterogeneous cancers should help identify interventions targeted to better combat this deadly disease. To analyze the radiation response of distinct glioma subpopulations, 2 glioma cells lines (U251, A172) were cultured under conditions that promoted either adherence or non-adherent spheroids. Past work has demonstrated that subpopulations derived from defined culture conditions exhibit differences in karyotype, proliferation, gene expression and tumorigenicity. Spheroid cultures from each of the glioma cell lines were found to be more radiosensitive, which was consistent with higher levels of oxidative stress and lower levels of both oxidative phosphorylation and glycolytic metabolism 1 week following irradiation. In contrast, radioresistant non-spheroid parental cultures showed increased glycolytic activity in response to irradiation, while oxidative phosphorylation was affected to a lesser extent. Overall these data suggest that prolonged radiation-induced oxidative stress can compromise the metabolic state of certain glioma subpopulations thereby altering their sensitivity to an important therapeutic intervention used routinely for the control of glioma.
Neurological Surgery, University of California, Irvine, CA, USA.
Chao
C
Ke
Katherine
K
Tran
Yumay
Y
Chen
Anne T
AT
Di Donato
Liping
L
Yu
Yuanjie
Y
Hu
Mark E
ME
Linskey
Ping H
PH
Wang
Charles L
CL
Limoli
Yi-Hong
YH
Zhou
D017209:Apoptosis / Q000528:radiation effects; D049109:Cell Proliferation / Q000528:radiation effects; D003114:Colony-Forming Units Assay; D004734:Energy Metabolism / Q000528:radiation effects; D005434:Flow Cytometry; D005910:Glioma / Q000145:classification / Q000473:pathology* / Q000532:radiotherapy*; D006019:Glycolysis / Q000528:radiation effects*; D006801:Humans; D010085:Oxidative Phosphorylation / Q000528:radiation effects*; D011836:Radiation Tolerance; D011839:Radiation, Ionizing; D018874:Spheroids, Cellular / Q000528:radiation effects*; D014407:Tumor Cells, Cultured